Inactive Instrument

Meso Numismatics, Inc. Stock Other OTC

Equities

MSSV

US59071L1035

Biotechnology & Medical Research

Sales 2022 1.53M 2.09M Sales 2023 2.41M 3.28M Capitalization 91.2K 124K
Net income 2022 -5M -6.81M Net income 2023 -9M -12.26M EV / Sales 2022 8.97 x
Net Debt 2022 13.5M 18.39M Net Debt 2023 17.12M 23.33M EV / Sales 2023 7.14 x
P/E ratio 2022
-0.04 x
P/E ratio 2023
-0.01 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 84.19%
More Fundamentals * Assessed data
Dynamic Chart
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Meso Numismatics, Inc. will Change its Name to Regenerative Medical Technology Group Inc CI
Meso Numismatics, Inc. Announces New Clinics CI
Meso Numismatics, Inc. Reports Sales Results for the Year 2023 CI
Meso Numismatics, Inc. Provides Earnings Guidance for the Fiscal Year 2024 CI
Meso Numismatics, Inc. announced that it expects to receive $10 million in funding from GHS Investments, LLC CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Meso Numismatics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Meso Numismatics, Inc. Auditor Raises 'Going Concern' Doubt CI
Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Meso Numismatics, Inc.'s Global Stem Cells Group Announces Launch of New Stem Cells and Regenerative Medicine Clinic in CDMX CI
Meso Numismatics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
More news
Managers TitleAgeSince
Chief Executive Officer 59 19-11-26
Members of the board TitleAgeSince
Chief Executive Officer 59 19-11-26
More insiders
Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.
More about the company